REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc., trading under the ticker PAIC, filed an 8-K current report with the Securities and Exchange Commission on May 7, 2026, under accession number 0001193125-26-212064. The company operates in the life sciences and biotechnology sector, with a research focus on immunological science and antiviral therapeutic development. As a post-SPAC public company in the healthcare biotechnology space, Revelation Biosciences represents the type of life-sciences de-SPAC name that warrants ongoing monitoring for material corporate events and business developments. The 8-K signals a reportable development under Exchange Act disclosure requirements. Sign up at SpacDesk for full filing history, sponsor data, and real-time SPAC analytics on PAIC and hundreds of other transactions.